Polygalloyltannin isolated from the roots of Acacia nilotica Del. (Leguminoseae) is effective against Plasmodium berghei in mice

Journal of Medicinal Plants Research

Volumn 4, Issue 12, 2010, Pages 1169-1175

  Jigam, Ali A ^a   Akanya, Helmina O ^a   Dauda, Bukar E N ^a   Okogun, J O ^b  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

Author keywords

Acacia nilotica; Bioguided assay 1H NMR spectra; Plasmodium berghei; Polygalloyltannin

Indexed keywords

1,3,6 DIGALLOYL 2,4 MONOGALLOYLTANNIN; ACACIA NILOTICA EXTRACT; ALKALOID; ANTIPROTOZOAL AGENT; CAFFEINE; CARDIAC GLYCOSIDE; CHLOROQUINE; FLAVONOID; GLYCOSIDE; METHANOL; MORPHINE; PHYTOSTEROL; POLYGALLOYTANNIN; SAPONIN; TANNIN DERIVATIVE; TERPENOID; UNCLASSIFIED DRUG;

ACACIA; ACACIA NILOTICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BIOASSAY; CONTROLLED STUDY; DECOMPOSITION; DRUG SCREENING; DRUG STRUCTURE; FEMALE; MALE; MELTING POINT; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PROTON NUCLEAR MAGNETIC RESONANCE; PURIFICATION;

ACACIA NILOTICA; MUS; PLASMODIUM BERGHEI;

EID: 77954839891     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Apponte JJ, Aide P, Renom M (2007). Safety of the RTS, S/ASO2D candidate malariavaccine in infants living in a highly endemic area of Mozambique: a double blind randomized controlled phase I/II b. Lancet 6(7): 1542-1546.
2. Banso A (2009). Phytochemical and Antibacterial Investigation of Bark Extracts of Acacia nilotica. J. Med. Plants. Res. 3(2): 82-85.
3. Bloland PB (2001). Drug resistance in Malaria. Background Document for WHO Global Strategy for Containment of Antimicrobial Resistance. WHO, Switzerland p. 3-27.
4. CCAC (1997). Canadian Council on Guidelines on Animal Care Guidelines. Protocol. Rev., 5: 12-26.
5. Dafallah AA, Al-Mustapha Z (1996). Investigation of the anti - inflammatory activity of Acacia nilotica and Hibiscus Sabdariffa, Ame. J. Chinese. Med. 24(3): 263-269.
6. El-Sayyad SM, Ross SA (1983). A phytochemcial study of some Cassia species cultivated in Egypt. J. Nat. Prod. Res. 46(3): 431-432.
7. Etkin NL (1997). Antimalarial plants used by Hausa in northern Nigeria. Trop. Doctor. 27(1): 12-16.
8. Fagg CW (1990). Acacia nilotica - Pioneer for dry lands. Department of University of Oxford UK Plant. Sci. 3: 15.
9. Fletcher E (2007). Traditional remedies - searching their natural sources for the next malaria drug. TDR news 79: 8-13.
10. Foster S (1994). Economic Prospects for a New Antimalarial Drug. Transactions of the Royal. Soc. Trop. Med. Hyg. 88: 55-56.
11. Gathirwa JW, Rukunga GM, Ngagi ENM, Omar SA, Guantai AN, Muthaura CN, Mwitari CG, Kimani CW, Kirira PG, Tolo FM, Ndunda TN, Ndiege IO (2007). In vitro antiplasmodial and in vivo anti malarial activity of some plants traditionally used for the treatment of malaria by the Meru community in Kenya. J. Nat. Med. 61: 261-268.
12. Giles C (2005). Why don't we have a malaria vaccine? Welcome Sci. 1: 12-13.
13. Gupta SK, Bokadia MM (1975). Flavonoids from the flowers of Acacia Arabica. Parishad Anusandhan Patrika, 18(1): 41-45.
14. Haidet A (2003). The medicinal values of the rainforest. Final paper on Tropical Field Courses Submitted to the Department of Interdisciplinary Studies at Miami Univ. USA.
15. Hien TT, White NJ (1993). Qinghaosu. Lancet. 341: 603-608.
16. Idro, R, Otieno G, White S, Kahindi A, Fegan G, Ogutu B, Mithwani S, Maitland K, Neville BG, Newton CR (2007). Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria, Mal. J. 4(57): 633-664.
17. Jigam AA (2008). Analysis of the Antimalarial Properties of Some Selected Medicinal Plants. A Doctoral Thesis Submitted to the Department of Biochemistry, Federal University of Technol. Minna, Nig. pp. 83-95.
18. Jigam AA, Akanya HO, Adeyemi JJ (2004). Antimicrobial and antiplasmodial effects of Momordica balsamina. Nig. J. Nat. Prod. Med. 8: 11-12.
19. Jigam AA, Akanya HO, Ogbadoyi EO, Dauda BEN, Evans EC (2009). In vivo antiplasmodial, analgesic and anti - inflammatory activities of the leaf extract of Lippia Multiflora. Mold. J. Med. Plants. Res. 3(3): 148-154.
20. Matuscheski K (2006). Vaccine development against malaria. Curr. Opin. Immunol. 18(4): 449-457.
21. Meshnick SR, Tsang TW, Lin FB (1996). Activated Oxygen Mediates the Antimalarial Activity of Qinghaosu. Liss Publishers, New York pp. 95-104.
22. Muthaura CN, Rukunga GM, Chhabra SC, Omar SA, Guantai AN, Gathirwa JW, Tolo FM, Mwitari PG, Keter LK, Kirira PG, Kimani CN, Mungai GM, Njagi EM (2007). Antimalarial activity of some plants traditionally used in treatment of malaria in Kwale district of Kenya. J. Ethnopharmacol. 112(3): 545-551.
23. Noedl H, Wongsrichanalai C, Wernsdorfer WH (2003). Malaria drug sensitivity testing: New assays, new perspectives. Trends Parasitol. 19: 175-181.
24. Odebiyi OO, Sofowora EA (1978). Phytochemical Screening of Nigerian Med. Plants. Lloydia 2(41): 234-235.
25. Puupponen, Pimia R, Nohynek L, Meier C, Kahkonen M, Hopia A, Oksman. Caldentey KM (2001). Antimicrobial properties of phenolic compounds from berries, J. Appl. Microbiol. 90(4): 494.
26. Sotohy SA, Sayed AN, Ahmed MM (1997). Effect of tannin - rich plant (Acacia nilotica) on some nutritional and bacteriological parameters in goats. DTW. Dutsh. Tierartzl. Wochenschr 104(10): 432-435.
27. Tagboto S, Townson S (2001). Antiparasitic properties of medicinal plants and other naturally occurring products. Adv. Parasitol. 50: 199-295.
28. Terry C (2000). Medicine from the Rain Forest: the ongoing quest for cures. The Rotarian 176(2): 18-21.
29. Trease GE, Evans WC (1989). Pharmacognosy. Bailliare Tindall London pp. 378-480.
30. Vogel AL (1964). A textbook of quantitative inorganic analysis. Longmans and Co London p. 181.
31. Waterman PG, Mole S (1994). Analysis of phenolic plant metabolites. Blackwell Scientific Publications, Oxford, UK pp. 50-54.
32. White NJ, Olliaro PL (1996). Strategies for the prevention of antimalarial drug resistance. Rationale for combination therapy for malaria. Parasitol. 12(10): 399-401.